FDA Inspection 741032 — Allos Therapeutics, Inc.
The FDA completed an inspection of Allos Therapeutics, Inc. on July 21, 2011 in Westminster, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 21, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Westminster, CO (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)